Dongwhane Lee1, Deok Hee Lee2, Dae Chul Suh2, Bum Joon Kim3, Sun U Kwon1, Hyuk Sung Kwon4, Ji-Sung Lee5, Jong S Kim1. 1. Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 2. Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 3. Department of Neurology, Kyung Hee University School of Medicine, Seoul, Korea. 4. Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea. 5. Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Korea.
Abstract
BACKGROUND AND PURPOSE: The outcome of endovascular treatment (EVT) may differ depending on the etiology of arterial occlusion. This study aimed to assess the differences in EVT outcomes in patients with intracranial arterial steno-occlusion (ICAS-O), artery-to-artery embolism (AT-O), and cardiac embolism (CA-O). METHODS: We retrospectively analyzed 330 patients with ischemic stroke who underwent EVT between January 2012 and August 2017. Patients were classified according to the etiology. The clinical data, EVT-related factors, and clinical outcomes were compared. The modified Rankin Scale (mRS) score at 3 months, determined using ordinal logistic regression (shift analysis), was the primary outcome. RESULTS: CA-O (n=149) was the most common etiology, followed by ICAS-O (n=63) and AT-O (n=49). Age, initial National Institutes of Health Stroke Scale (NIHSS) score, and rate of hemorrhagic transformation were significantly higher in patients with CA-O compared to AT-O and ICAS-O. The time from onset-to-recanalization was the shortest in the CA-O (356.0 minutes) groups, followed by the AT-O (847.0 minutes) and ICAS-O (944.0 minutes) groups. The rates of successful recanalization, mRS distribution, and favorable outcomes at 3 months (mRS 0-2; CA-O, 36.9%, AT-O, 53.1%; and ICAS-O, 41.3%) did not differ among the three groups. Baseline NIHSS score (odds ratio, 0.87; 95% confidence interval, 0.83 to 0.91) could independently predict a favorable shift in mRS distribution. CONCLUSIONS: The functional outcomes of ICAS-O and AT-O were similar to those of CA-O, despite the delay in symptom onset-to-recanalization, suggesting that the therapeutic time window may be extended in these patients.
BACKGROUND AND PURPOSE: The outcome of endovascular treatment (EVT) may differ depending on the etiology of arterial occlusion. This study aimed to assess the differences in EVT outcomes in patients with intracranial arterial steno-occlusion (ICAS-O), artery-to-artery embolism (AT-O), and cardiac embolism (CA-O). METHODS: We retrospectively analyzed 330 patients with ischemic stroke who underwent EVT between January 2012 and August 2017. Patients were classified according to the etiology. The clinical data, EVT-related factors, and clinical outcomes were compared. The modified Rankin Scale (mRS) score at 3 months, determined using ordinal logistic regression (shift analysis), was the primary outcome. RESULTS: CA-O (n=149) was the most common etiology, followed by ICAS-O (n=63) and AT-O (n=49). Age, initial National Institutes of Health Stroke Scale (NIHSS) score, and rate of hemorrhagic transformation were significantly higher in patients with CA-O compared to AT-O and ICAS-O. The time from onset-to-recanalization was the shortest in the CA-O (356.0 minutes) groups, followed by the AT-O (847.0 minutes) and ICAS-O (944.0 minutes) groups. The rates of successful recanalization, mRS distribution, and favorable outcomes at 3 months (mRS 0-2; CA-O, 36.9%, AT-O, 53.1%; and ICAS-O, 41.3%) did not differ among the three groups. Baseline NIHSS score (odds ratio, 0.87; 95% confidence interval, 0.83 to 0.91) could independently predict a favorable shift in mRS distribution. CONCLUSIONS: The functional outcomes of ICAS-O and AT-O were similar to those of CA-O, despite the delay in symptom onset-to-recanalization, suggesting that the therapeutic time window may be extended in these patients.
Authors: Sang Hee Ha; Jae-Chan Ryu; Jae-Han Bae; Sujin Koo; Boseong Kwon; Yunsun Song; Deok Hee Lee; Jun Young Chang; Dong-Wha Kang; Sun U Kwon; Jong S Kim; Bum Joon Kim Journal: Neurol Sci Date: 2022-07-13 Impact factor: 3.830
Authors: Sapna Erat Sreedharan; K Arun; Santhosh Kannath; E R Jayadevan; Jissa V Thulaseedharan; P N Sylaja Journal: Ann Indian Acad Neurol Date: 2022-03-25 Impact factor: 1.714
Authors: Jin Soo Lee; Seong-Joon Lee; Ji Man Hong; Francisco José Arruda Mont Alverne; Fabricio Oliveira Lima; Raul G Nogueira Journal: J Stroke Date: 2022-01-31 Impact factor: 6.967